Synlogic, Inc.
🏢 View company profile →4Patents
4Active
4Granted
48Portfolio score
Filing activity: Dec 4, 2015 → Sep 8, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9688967B2 | Bacteria engineered to treat diseases associated with hyperammonemia | Chemistry; Metallurgy | 26 | Active |
| US9487764B2 | Bacteria engineered to treat diseases associated with hyperammonemia | Emerging Cross-Sectional Technologies | 21 | Active |
| US9889164B2 | Bacteria engineered to treat a disease or disorder | Emerging Cross-Sectional Technologies | 18 | Active |
| US9943555B2 | Bacteria engineered to reduce hyperphenylalaninemia | Emerging Cross-Sectional Technologies | 4 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.